Milestone Pharmaceuticals Inc
MIST
Company Profile
Business description
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
Contact
1111 Dr. Frederik-Philips Boulevard
Suite 420
MontrealQCH4M 2X6
CANT: +1 514 336-0444
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
33
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,770.20 | 79.30 | 0.91% |
| CAC 40 | 7,804.67 | 40.83 | 0.53% |
| DAX 40 | 24,276.48 | 184.86 | 0.77% |
| Dow JONES (US) | 42,490.36 | 29.28 | -0.07% |
| FTSE 100 | 8,801.29 | 14.27 | 0.16% |
| HKSE | 23,654.03 | 141.54 | 0.60% |
| NASDAQ | 19,413.81 | 14.85 | 0.08% |
| Nikkei 225 | 37,747.45 | 300.64 | 0.80% |
| NZX 50 Index | 12,494.71 | 167.48 | 1.36% |
| S&P 500 | 5,969.69 | 0.68 | -0.01% |
| S&P/ASX 200 | 8,541.80 | 75.10 | 0.89% |
| SSE Composite Index | 3,376.20 | 14.23 | 0.42% |